AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
Ram Hari Pokhrel(Yeungnam University), Jae‐Hoon Chang(Yeungnam University)
Cited by 81
Related Papers
Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
|Nature Communications|2023|71
Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment
|ACS Nano|2024|48
Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment
|Journal of Controlled Release|2023|21
AMPK suppresses Th2 cell responses by repressing mTORC2
|Experimental & Molecular Medicine|2022|19
AMPK Amplifies IL2–STAT5 Signaling to Maintain Stability of Regulatory T Cells in Aged Mice
|International Journal of Molecular Sciences|2022|18